Obicetrapib

Drug / Medication

A potent CETP inhibitor from Mitsubishi Tanabe Pharma that lowers LDL by 50% on top of statins and dramatically increases HDL, showing promise for various diseases including Alzheimer's, septicemia, and diabetes.

Mentioned in 1 video

Videos Mentioning Obicetrapib

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

255-Latest therapeutics in CVD, APOE’s role in Alzheimer’s disease, familial hypercholesterolemia

Peter Attia MD

A potent CETP inhibitor from Mitsubishi Tanabe Pharma that lowers LDL by 50% on top of statins and dramatically increases HDL, showing promise for various diseases including Alzheimer's, septicemia, and diabetes.